Annual D&A:
$7.37M+$3.81M(+106.82%)Summary
- As of today, KYMR annual D&A is $7.37 million, with the most recent change of +$3.81 million (+106.82%) on December 31, 2024.
- During the last 3 years, KYMR annual D&A has risen by +$4.98 million (+207.59%).
- KYMR annual D&A is now at all-time high.
Performance
KYMR Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$2.15M+$65.00K(+3.12%)Summary
- As of today, KYMR quarterly D&A is $2.15 million, with the most recent change of +$65.00 thousand (+3.12%) on September 30, 2025.
- Over the past year, KYMR quarterly D&A has increased by +$162.00 thousand (+8.15%).
- KYMR quarterly D&A is now at all-time high.
Performance
KYMR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$8.27M+$162.00K(+2.00%)Summary
- As of today, KYMR TTM D&A is $8.27 million, with the most recent change of +$162.00 thousand (+2.00%) on September 30, 2025.
- Over the past year, KYMR TTM D&A has increased by +$1.99 million (+31.72%).
- KYMR TTM D&A is now at all-time high.
Performance
KYMR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
KYMR Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +106.8% | +8.2% | +31.7% |
| 3Y3 Years | +207.6% | +180.2% | +190.3% |
| 5Y5 Years | +793.7% | +338.6% | +408.2% |
KYMR Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +207.6% | at high | +180.2% | at high | +190.3% |
| 5Y | 5-Year | at high | +793.7% | at high | +343.1% | at high | +408.2% |
| All-Time | All-Time | at high | +3496.6% | at high | +495.3% | at high | +2190.3% |
KYMR Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $2.15M(+3.1%) | $8.27M(+2.0%) |
| Jun 2025 | - | $2.08M(+1.8%) | $8.11M(+1.8%) |
| Mar 2025 | - | $2.05M(+3.1%) | $7.96M(+8.0%) |
| Dec 2024 | $7.37M(+106.8%) | $1.99M(0.0%) | $7.37M(+17.5%) |
| Sep 2024 | - | $1.99M(+2.5%) | $6.28M(+21.1%) |
| Jun 2024 | - | $1.94M(+32.6%) | $5.18M(+25.0%) |
| Mar 2024 | - | $1.46M(+64.0%) | $4.15M(+16.3%) |
| Dec 2023 | $3.56M(+19.8%) | $891.00K(-0.4%) | $3.56M(+2.1%) |
| Sep 2023 | - | $895.00K(-0.6%) | $3.49M(+3.8%) |
| Jun 2023 | - | $900.00K(+2.4%) | $3.36M(+6.2%) |
| Mar 2023 | - | $879.00K(+7.5%) | $3.17M(+6.4%) |
| Dec 2022 | $2.98M | $818.00K(+6.6%) | $2.98M(+4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $767.00K(+8.8%) | $2.85M(+3.5%) |
| Jun 2022 | - | $705.00K(+2.6%) | $2.75M(+5.9%) |
| Mar 2022 | - | $687.00K(-0.3%) | $2.60M(+8.4%) |
| Dec 2021 | $2.40M(+36.0%) | $689.00K(+2.7%) | $2.40M(+8.7%) |
| Sep 2021 | - | $671.00K(+21.6%) | $2.21M(+8.9%) |
| Jun 2021 | - | $552.00K(+13.8%) | $2.02M(+8.8%) |
| Mar 2021 | - | $485.00K(-2.4%) | $1.86M(+5.6%) |
| Dec 2020 | $1.76M(+113.7%) | $497.00K(+1.4%) | $1.76M(+8.4%) |
| Sep 2020 | - | $490.00K(+26.0%) | $1.63M(+43.1%) |
| Jun 2020 | - | $389.00K(+0.5%) | $1.14M(+52.0%) |
| Mar 2020 | - | $387.00K(+7.2%) | $748.00K(+107.2%) |
| Dec 2019 | $825.00K(+302.4%) | $361.00K | $361.00K |
| Dec 2018 | $205.00K | - | - |
FAQ
- What is Kymera Therapeutics, Inc. annual D&A?
- What is the all-time high annual D&A for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. annual D&A year-on-year change?
- What is Kymera Therapeutics, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Kymera Therapeutics, Inc. TTM D&A?
- What is the all-time high TTM D&A for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. TTM D&A year-on-year change?
What is Kymera Therapeutics, Inc. annual D&A?
The current annual D&A of KYMR is $7.37M
What is the all-time high annual D&A for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high annual D&A is $7.37M
What is Kymera Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, KYMR annual D&A has changed by +$3.81M (+106.82%)
What is Kymera Therapeutics, Inc. quarterly D&A?
The current quarterly D&A of KYMR is $2.15M
What is the all-time high quarterly D&A for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high quarterly D&A is $2.15M
What is Kymera Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, KYMR quarterly D&A has changed by +$162.00K (+8.15%)
What is Kymera Therapeutics, Inc. TTM D&A?
The current TTM D&A of KYMR is $8.27M
What is the all-time high TTM D&A for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high TTM D&A is $8.27M
What is Kymera Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, KYMR TTM D&A has changed by +$1.99M (+31.72%)